Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-30

FDA Approved: DAPTOMYCIN IN SODIUM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approves Baxter's supplemental application for daptomycin in sodium chloride, adding a saline formulation of the antibiotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Daptomycin in Sodium Chloride (Daptomycin)

Snippet

SUPPL AP for DAPTOMYCIN IN SODIUM CHLORIDE (DAPTOMYCIN IN SODIUM CHLORIDE)